TMCnet

Milestone Pharmaceuticals to Announce Fourth Quarter and Full-Year 2025 Financial Results on March 20, 2026

Milestone Pharmaceuticals Inc. (Nasdaq: MIST) is a biopharmaceutical company developing and commercializing innovative cardiovascular medicines to benefit people living with certain heart conditions.

Tonix Pharmaceuticals Presented Data on TONMYATM in Treating Patients with Fibromyalgia at the 2026 AAPM PainConnect Annual Meeting

Detailed price information for Tonix Pharm Holdings (TNXP-Q) from The Globe and Mail including charting and trades.

Tonix Pharmaceuticals Announces Publication of Clinical Pharmacokinetic Studies of TONMYA™ and Prototype Formulations in the Journal Clinical Pharmacology in Drug Development

Detailed price information for Tonix Pharm Holdings (TNXP-Q) from The Globe and Mail including charting and trades.
Scientific Research Publishing

Uncontrolled Hypothyroidism with Antiphospholipid Syndrome Resulting in Myxedema Psychosis ()

Khan, S. and Issa, H. (2026) Uncontrolled Hypothyroidism with Antiphospholipid Syndrome Resulting in Myxedema Psychosis. Open Journal of Psychiatry, 16, 131-138. doi: 10.4236/ojpsych.2026.162010 .